Abbott, Ferrero & Strauss – Oh, My!

Analysis and Op-Ed

Although the names sound as though they belong on the letterhead of a law practice, or of an accounting firm, Abbott Nutrition, Ferrero International, and Strauss Group are three distinct companies, located in North America, Europe, and the Middle East, respectively.

Each of these companies is currently managing multinational product recalls.

And two of the recalls have been associated with outbreaks of foodborne disease.

Strauss – Elite Chocolate

On April 19, 2022, Strauss notified Israel’s Ministry of Health that routine testing had revealed the presence of Salmonella “in the manufacturing area” of the company’s Nof HaGlil’ production facility.

The factory manufactures a range of Elite brand chocolate products, and also supplies chocolate to other food processors.

The Ministry of Health instructed Strauss to conduct more extensive tests on its finished products, raw materials, and production environment.

On April 21, 2022, using a rapid test, Strauss found indications of Salmonella in some raw material.

It took an additional three days to confirm these preliminary positive results, during which time no warning was issued to the public. Nor, as far as we can tell, was any product put on hold.

On April 24, 2022, once the preliminary results had been confirmed, Strauss initiated a recall of multiple Elite chocolate products, explaining that Salmonella had been discovered in the production line at the company’s Nof HaGlil’ manufacturing plant. Samples of chocolate used as an ingredient for other products also tested positive for Salmonella.

On April 25, 2022, Unilever Israel recalled multiple ice cream products that contained chocolate supplied by Strauss.

On April 27, 2022, more than one full week after first reporting the presence of Salmonella in the production plant, Strauss expanded its recall to include all expiration dates of all products manufactured by Elite’s chocolate factory, including Elite cakes, Elite wafers, cereal energy bars, chocolate-coated energy rice crisps, bubble gums and taffy candies.

The company has suspended operations at the manufacturing facility while it conducts and investigation into the cause and source of the contamination and carries out an intensive cleaning and sanitizing of the production area.

In addition to being sold throughout Israel, products manufactured in the Nof HaGlil’ facility were exported to multiple countries, including Australia, Austria, Canada, France, Germany, Hungary, Italy, Netherlands, New Zealand, Poland, Romania, Spain, United Kingdom and United States.

Although Israel’s Ministry of Health has not announced any indications of an outbreak linked to the recalled chocolates, The Jerusalem Post reported that a 10-year-old boy was diagnosed with Salmonella on April 27th after being admitted to hospital with severe dehydration as a result of extensive vomiting and diarrhea.

Ferrero – Kinder chocolate products

On December 15, 2021, Ferrero detected Salmonella on the surface and in residual raw materials samples taken from buttermilk tanks in its Arlon, Belgium manufacturing facility.

The company did not notify the Belgian food safety authority of this finding until early April 2022.

Instead, Ferrero suspended production, destroyed the affected semi-finished product, carried out a deep cleaning of the entire line, and resumed production. Finished product manufactured on the line was released for distribution following negative test results.

Additional samples tested in January 2022 also were positive for Salmonella, including two samples from two buttermilk tanks, recorded on January 11th.

As before, the company suspended production, deep-cleaned the line and gradually resumed production.

On February 17, 2022, the UK reported a cluster of monophasic Salmonella Typhimurium cases to the European Centre for Disease Control (ECDC).

Between January 5th and February 8th, Ferrero had submitted nine Salmonella cultures to an Italian lab for serological and molecular typing.

Four of those cultures were a match for the outbreak strain.

By April 8, 2022, the ECDC had received reports of 150 cases from nine EU countries and the UK.

Most of the cases were in children less than ten years of age, and many of the children were hospitalized.

On April 8th, the Belgian food safety authority withdrew its production authorization for Ferrero’s Arlon manufacturing facility, announcing that it could not rely on the information the company had been providing.

That same day, Ferrero recalled all of the Kinder chocolate products manufactured in the Arlon facility.

As of April 19th, the number of cases had risen to 187 cases in 11 EU countries and the UK.

On April 22, 2022, the company expanded its recall to include additional products.

Abbott Nutrition – Powdered infant formula

It could be argued that Strauss’s delay in recalling its chocolate products was relatively minor and without any significant impact on public health.

It is more difficult to justify a similar argument in the case of Ferrero.

Had the company destroyed the finished products impacted by its buttermilk contamination rather than testing and releasing, a multi-national Salmonella outbreak most likely would have been avoided.

Yet, Ferrero’s actions pale in comparison to the situation at Abbott Nutriton’s Sturgis, Michigan production facility, as alleged in a whistleblower complaint lodged with the FDA last October.

According to the whistleblower, company management has been falsifying records, shortchanging preventative maintenance, skimping on sanitation, and turning a blind eye to microbiological problems in the plant.

While we have only the whisteblower’s word for many of the allegations, some of what he or she has reported has been substantiated in the FDA’s Establishment Inspection Reports from September 2019 and September 2021, and in the Inspectional Observations (FDA Form 483) documented during the January – March 2022 investigation of the Sturgis facility, as described in earlier eFoodAlert posts.

FDA actions vis-a-vis Abbott Nutrition

The apparent ease with which Abbott allegedly pulled the wool over the eyes of FDA inspectors during the 2019 and 2021 inspections is troubling, to say the least.

Even though the inspectors were advised during the September 2021 plant visit of consumer complaints of Salmonella infections associated with Abbott products, they did not carry out any independent environmental sampling during the course of their plant visits. Instead, they relied on the company’s reports of how the complaints were investigated and deemed to be unsubstantiated.

Reports of equipment maintenance also were taken at face value, as were sanitation records.

Coincidentally, while the FDA inspectors were on site at Abbott in September 2021, the agency was alerted to the first of four confirmed reports of Cronobacter sakazakii in an infant who had been fed an Abbott powdered infant formula.

The following month, on October 20, 2021, the whistleblower complaint was submitted to the FDA.

The agency did not get around to interviewing the whistleblower until late December, and the FDA did not begin its in-depth investigation into the operations of Abbott’s Sturgis facility until January 31, 2022.

By then, two additional reports of Cronobacter-infected infants and one report of a Salmonella-infected infant had been lodged with the FDA.

Before the completion of the January – March 2022 Abbott inspection, a fourth Cronobacter-infected infant was identified.

TWO OF THE FOUR CRONOBACTER-INFECTED INFANTS DIED.

What next for food safety?

Had Ferrero been living up to its responsibility to produce safe food, there would have been no outbreak of Salmonella Typhimurium in Europe and the UK.

Had Abbott been living up to its responsibility, the four infants would not have become infected with Cronobacter, and the parents of the two dead babies would have been spared a lifetime of grieving.

Likewise, had the FDA lived up to its responsibilities, Abbott’s behavior might have come to light at least two years ago, and the company would have been brought to heel.

There is no excuse for Ferrero, for Abbott Nutrition, or for the FDA.

It is time for food companies who flout good manufacturing practices and who put consumers at risk to pay for their malfeasance.

And it is past time for the US Congress to take a good, long, hard look at the way in which food safety is overseen in the United States.


Learn more about Salmonella in chocolate and Cronobacter sakazakii in infant formula in TAINTED. From Farm Gate to Dinner Plate, Fifty Years of Food Safety Failures, now available in digital, print and audiobook editions.

TAINTED formats 3
“Reads like a true crime novel” – Food Safety News

Abbott Nutrition: What price profits?

In the calendar year 2021, Abbott Laboratories, the parent company of Abbott Nutrition, spent almost $2.3 BILLION to repurchase shares of its stock.

This was in addition to $403 million spent for the same purpose in 2020, $718 million in 2019, and $238 million in 2018.

In 2020, Abbott Laboratories’ net profits were in excess of $7 BILLION, an increase of more than 57% over the net profits of the year before.

Between September 2019 and January 2022, while the corporation’s profits soared and Abbott Laboratories plowed billions of dollars into a stock buy-back program, maintenance and quality control issues at Abbott Nutrition’s Sturgis plant snowballed.

Early warnings

The early warning signals were evident during the FDA’s 2019 annual inspection of the company’s manufacturing facility, as documented in the Establishment Inspection Report, obtained by eFoodAlert in response to a Freedom of Information Act request.

Between September 2018 and September 2019, both the FDA and the company received several complaints of illnesses among babies who had been fed a Similac infant formula product. These included:

  • A report from a Pediatric Nurse Practitioner that five babies under the practitioner’s care had suffered from projectile vomiting after consuming Similac Sensitive Infant Formula (multiple batch codes).
  • An infant diagnosed with Enterobacter (Cronobacter) sakazakii after consuming three different infant formula products, two of which were Similac products. The infant was treated with antibiotics and recovering.
  • A baby was infected with Salmonella after consuming a specific batch code Similac Total Comfort infant formula.
  • An infant consumed Similac Sensitive infant formula and developed high temperature and vomiting. The infant was diagnosed with Salmonella.
  • A male baby tested positive for Salmonella after consuming a batch of Similac Sensitive infant formula.
  • A baby possibly infected with Salmonella after having been fed two different batches of Similac Sensitive.
  • A baby being fed Similac Advance formula died. The cause of death was unknown

The company responded to all of these complaints by conducting reviews of its records for similar complaints (none found), reviewing batch records, and the results of microbiological tests conducted at the time of manufacture.

In some cases, the company conducted microbiological tests of retained samples from the indicated batches, with uniformly negative results.

In response to the Cronobacter complaint, Abbott also carried out microbiological testing on the consumer’s opened product, with negative results.

In addition to the consumer complaints, the company’s own lab found Cronobacter in a sample of Alimentum Advance Powder on August 5, 2019, during the course of routine finished-product testing activities.

In response, Abbott quarantined the Cronobacter-positive batch, in addition to the batches produced immediately before and after the contaminated batch.

After investigating the source of the contamination, the firm identified the root cause as being “…due to a non-routine intervention.”

According to the company’s records, the firm identified and implemented corrective actions, and designated the contaminated batch for destruction.

Environmental monitoring results from after the “non-routine intervention” showed two fails followed by two pass results (ie., Cronobacter-negative) on follow-up.

The 2019 FDA inspection

The FDA’s 2018 inspection resulted in the Sturgis facility receiving a clean bill of health. In fact, all of the prior inspections of this location from 2011 through 2018 were without adverse observations, according to the FDA inspection database.

The 2019 Establishment Inspection Report (EIR) describes the FDA visit as a “comprehensive surveillance inspection” which was conducted as part of the Infant Formula Program and Medical Foods Program.

However, even with the history of complaints, the agency conducted only a superficial lab investigation. FDA inspectors obtained samples of two finished products to conduct nutrient analysis and microbiological tests.

Both finished products yielded negative test results for both Cronobacter and Salmonella.

Despite Abbott’s acknowledgment of having found Cronobacter in a finished product and in the environment, the inspection did not included any raw material, in-process, or environmental sampling.

The visual inspection observations included in the EIR indicate a production plant that appeared to be in good repair, with proper attention given to maintenance and sanitation.

There was no evidence of insect or rodent infestation, and no birds flying through the production or warehouse areas.

The inspectors reviewed the company’s maintenance records, and noted repairs to small cracks and pitted areas along the production lines and on the exterior and inside of dryers.

The only significant negative observation was an error in sampling finished product for microbiological testing. A technician was seen to draw only 30 samples from a production lot instead of the 60 samples required under the sampling plan.

The two-year gap

Whether due to the Covid-19 pandemic or to some other reason, there was no annual inspection of Abbott Nutrition’s Sturgis location in 2020.

When the FDA inspectors returned to Sturgis in September 2021, they found a very different situation. At the completion of their five-day inspection, they issued a formal list of Inspectional Observations (FDA Form 483).

  • Standing water in multiple locations
  • Processing operator not sanitizing or changing gloves after touching non-food contact surfaces, before going on to touch food contact surfaces
  • Lack of calibration of flow meters, pressure sensors and a flow sensor on the product line
  • Inadequate frequency of temperature monitoring for a pasteurizer, even though temperature was identified as a Critical Control Point for the product in question.

The Form 483 leaves multiple questions unanswered:

  • What consumer complaints were lodged with either the FDA or the company during the two years between inspections?
  • Did the FDA conduct environmental, raw material, or finished product testing as part of this inspection?
  • What other observations were noted during the inspection that did not rise to the level of a formal “Inspectional Observation?”
  • Were the inspectors aware at the time they were on location that the FDA had received a Cronobacter sakazakii illness report linked to an Abbott Nutriton product?

Answers to at least some of these questions should be contained in the full Establishment Inspection Report. eFoodAlert has requested, but has not yet received, a copy of the full report.

Even in the absence of the full report of the September 2021 inspection, it is clear from the contents of the Form 483 issued at the completion of the January-March 2022 inspection that conditions in the Sturgis plant had deteriorated significantly since 2019.

  • Environmental samples collected near the start of the FDA inspection revealed the presence of Cronobacter sakazakii in multiple locations. Whole genome sequencing determined that five different strains of the pathogen were present in the plant environment.
  • Between the end of the September 2019 inspection and February 20, 2022, Abbott’s own testing activities documented at least eight instances of Cronobacter contamination in the environment and two instances of Cronobacter in finished products.
  • A review of Work Orders revealed multiple instances of water leaks, including one location that was the source of three separate leaks over the course of a year.
  • A total of 310 “water events” documented by the company between January 1, 2020 and February 1, 2022, including water leaks, moisture and condensation in dry powdered infant formula production areas. These events were not associated with routine clean-in-place equipment cycles.
  • A history of internal deterioration of dryers dating back to September 2018, including multiple instances of pits and cracks inside the main chambers of at least two dryers.
  • Inadequate follow-up of consumer complaints received by FDA beginning in September 2021 regarding Cronobacter sakazakii and Salmonella illnesses potentially associated with three different Similac dry infant formula products.

How was this allowed to happen?

Both Abbott Nutrition and the FDA have a lot to answer for.

Ever since a baby died from a Cronobacter sakazakii infection in Tennessee in 2001, the FDA has repeatedly claimed that ensuring the safety of infant formulas was a high priority for the agency.

Yet, the agency allowed two years to elapse between inspections of Abbott Nutrition’s more than sixty-year-old production facility in Sturgis, Michigan.

This lapse, however, does not excuse Abbott’s lack of care.

Food manufacturers–especially those that serve vulnerable populations such as infants–are legally, morally, and ethically bound to ensure the safety of all of their products.

There is no excuse for Abbott’s having abrogated its responsibilities to its customers. Certainly, the company cannot plead poverty as a reason for having neglected to properly maintain its production equipment and manufacturing environment.


Learn more about Cronobacter sakazakii and other foodborne disease outbreaks in TAINTED. From Farm Gate to Dinner Plate, Fifty Years of Food Safety Failures, now available in digital, print and audiobook editions.

TAINTED formats 3
“Reads like a true crime novel” – Food Safety News

Recalls and Alerts: March 24-25, 2022

TAINTED formats 3

Here is today’s list of food safety recalls, product withdrawals, allergy alerts and miscellaneous compliance issues. The live links will take you directly to the official recall notices and company news releases that contain detailed information for each recall and alert.

If you would like to receive automatic email alerts for all new articles posted on eFoodAlert, please submit your request using the sidebar link.

Interested in learning more about food safety and the history of foodborne disease outbreaks and investigations? Click on the TAINTED menu at the top of the page to read or listen to a short excerpt, then follow the buy links to add a digital, print or audio copy to your personal library.

Listen to an excerpt of the new audiobook edition right here

Chapter 6. Birth of a Pathogen

United States

Allergy Alert: A&C Best Food Trading Inc. recalls Dried Wife Plum (Date code 2021/10/15) due to undeclared sulphites.

Allergy Alert: SunTree Snack Foods LLC recalls Good & Gather Dried Sweetened Strawberries (4 oz; Lot code 88514 / Best by 10/01/2022, 10/04 – 10/07/2022, 10/11 – 10/14/2022; Lot code 86061 / Best by 09/01/2022; UPC 085239182840) due to undeclared sulphites.

Allergy Alert: FSIS issues public health alert due to concerns that the chicken breast component of ready-to-eat (RTE) chicken breast meal kits due to undeclared wheat and soy. Please refer to the FSIS notice for a complete list of affected products.

Canada

Food Safety Recall: P&P au bon goût (Repentigny, QC) recalls ÉPICES CRÉOLES – NON PIQUANT / Mild Créole spices and ÉPICES CRÉOLES – PIQUANT / Hot Créole spices (500 ml; Units sold up to 24 March 2022) due to possible food safety hazard.

Food Safety Recall: Stellar Bay Shellfish recalls Stellar Bay Shellfish brand Chef Creek Oysters (Harvest Area BC 14-8; Deep Bay CLF #0278737; Harvested and processed 03-07-22) due to Norovirus contamination. The recalled products have been sold in British Columbia and may have been distributed in other provinces and territories. There have been reported illnesses associated with the consumption of these products.

Food Safety Recall: Jimel’s Bakery and Food Products recalls Jimel’s Bakery brand baked goods due to possible Salmonella contamination from rodent infestation. The recalled products have been sold in Manitoba. There have been reported illnesses that may be associated with the consumption of these products. Please refer to the recall notice for a complete list of affected products.

Europe

Allergy Alert (Belgium): Jumbo Supermarkten recalls Jumbo tortilla naturel XL (370g; Lot L422063; Best before 04/09/2022) due to undeclared barley.

Allergy Alert (Italy): Mia Food SRL recalls 44 brand Spezia Margaz / Margaz spice (1 kg; Lots 628, 632, 634) due to undeclared sulphites.

Allergy Alert (Netherlands): Albert Heijn recalls AH bokkenpoten / goat leg pastries (Best before 07-04-2022) due to undeclared soy, nuts and almonds.

Allergy Alert (Spain): FRIT RAVICH brand Butter-flavoured popcorn (80g; Batch No. 22101; Best before 07/07/2022) contains undeclared mustard.

Food Safety Recall (Belgium): Delhaize recalls three products containing pistachios due to elevated aflatoxin levels. Please refer to the recall notice for a complete list of affected products.

Food Safety Recall (France): COMPAGNIE ALIMENTAIRE recalls Maison Naja brand Figues Lérida biologiques / Organic Lérida figs (330g; Best before 15/11/2022, 18/11/2022 & 28/04/2023) due to elevated ochratoxin level.

Food Safety Recall (France): LA CONSERVERIE DES SAVEURS recalls conserverie des saveurs brand terrine de canard aux figues caramélisées / Duck terrine with caramelized figs (140 ml; Lot 21271-B74 21271B68; Best before 28/09/2024) due to foreign matter contamination (metal piece).

Food Safety Recall (France): Thalassa Excellence recalls Fumage du val de lys brand Fletan fumé / Smoked halibut (150g; Lot 22070044; Use by 31/03/2022) due to Listeria monocytogenes contamination.

Food Safety Recall (France): LES FLEURONS recalls LES FLEURONS brand Figues Extra Moelleuses BIO / Organic extra-soft figs (250g; Lot 3555; Best before 31/05/2023) due to elevated ochratoxin level.

Food Safety Recall (France): Brousse Vergez recalls Brousse brand Figues séchées Lerida Biologiques / Organic dried Lerida figs (5 kg carton; Lot 440024553/1-11-372; Best before 30/10/2022) due to elevated ochratoxin level.

Food Safety Recall (France): SILVAREM INTERNATIONAL recalls BROUSSE VERGEZ brand Figues LERIDA Biologique / Organic Lerida figs (5 kg carton; Lot 440024553/1-11-372; Best before 30/10/2022) due to elevated ochratoxin level.

Food Safety Recall (Germany): Kosebate GmbH recalls Alburj – Halva mit extra Pistazien / Halva with extra pistachios (800g; Production date 07.02.2021) due to Salmonella contamination.

Food Safety Recall (Germany): Abbott Nutrition (Sturgis, MI, USA) recalls Similac, Alimentum and EleCare powdered infant formula due to risk of contamination with Salmonella Newport and Cronobacter sakazakii.

Food Safety Recall (Germany): Fresh Nuts GmbH recalls Kerem – mini Feige / Mini figs (250g; Lots 21002960, 21003123, 21003122, 22000191; Expiry 30.04.2022; Product of Spain) due to elevated ochratoxin level.

Food Safety Recall (Iceland): Eðalfiskur ehf recalls Úrvals grafnar sneiðar, Úrvals grafinn lax (bitar), Úrvals grafinn lax (flök) / Gravlax products (Lots IB22038041046, IB22038041049 & IB22038042048; Expiry dates 13.3.2022-11.4.2022) due to possible Listeria monocytogenes contamination.

Food Safety Recall (UK): Parsons Pickles recalls Parson’s Pickles Pickled Mussels (155g; Lot 327; Batch38V supplied to B&M Stores Only; Best before end of Nov 2024) due to foreign matter contamination (glass fragments).

Australia and New Zealand

Food Safety Recall (Australia): Malt Brewing Co PTY LTD t/a Revel Brewing Co recalls Pine Lime Sour Ale (375 ml; Package date 27.1.2022) due to possible secondary fermentation that could lead to illness or injury.